Skip to main content

Pops Richard F

In the past year, 1 open-market sale filing worth $2.36M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$2.36M
1 filing
Net
−$2.36M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Pops Richard F as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

NBIX Neurocrine Biosciences Inc

Director7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 18, 2026 (view filing)May 153 daysPops Richard FDirectorSSale−15.0K$157.65−$2.36M−30.3%34.5K after10b5-1
May 21, 2024 (view filing)May 174 daysPops Richard FDirectorSSale−2.10K$141.84−$297.9K−6.2%31.6K after10b5-1
Mar 15, 2024 (view filing)Mar 132 daysPops Richard FDirectorSSale−23.2K$140.33−$3.26M−44.0%29.5K after10b5-1
Mar 12, 2024 (view filing)Mar 8-114 daysPops Richard FDirectorSSale−1.80K$140.05−$252.1K−5.7%29.5K after2 lots10b5-1
Feb 22, 2024 (view filing)Feb 202 daysPops Richard FDirectorSSale−15.0K$132.47−$1.99M−33.7%29.5K after10b5-1
Jan 5, 2023 (view filing)Jan 32 daysPops Richard FDirectorSSale−15.0K$119.20−$1.79M−33.7%29.5K after
May 11, 2022 (view filing)May 92 daysPops Richard FDirectorSSale−15.0K$76.30−$1.14M−33.7%29.5K after2 lots

ALKS Alkermes plc.

Director and CEO, Alkermes plc1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 6, 2022 (view filing)May 5-61 dayPops Richard FDirector and CEO, Alkermes plcSSale−347.3K$27.98−$9.72M−26.4%968.3K after3 lots